Prognosis Study of Renal Transplantation in Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

184 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-01

Study Completion Date

2021-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Kidney transplantation is the worldwide recognized best renal replacement treatment for children with end-stage renal disease. Successful kidney transplantation can not only alleviate uremia symptoms, improve survival and quality of life, but also achieve optimal growth and cognitive development in children. Clarifying the cause of end-stage renal disease before transplantation is of vital importance to the comprehensive assessment and follow-up of the extra renal organs, reducing the risk of recurrence of the primary disease, the choice of the timing and the mode of transplantation, the scheme of immunosuppressive agents, as well as providing accurate genetic counseling for families. Timely molecular diagnosis and correct data analysis play a positive role in promoting the etiological diagnosis of uremic children before renal transplantation. We hypothesized that identifying the molecular diagnosis can improve prognosis of kidney transplantation. 300 cases of end-stage renal disease children were included and whole exome sequencing are performed to identify the molecular diagnosis. The cohort was divided into 2 groups according to whether the molecular diagnosis was clear. Clinical information before and after renal transplantation of each group are collected, and the decision tree analysis model and logistic regression model are used to study the effect of clear molecular diagnosis on the 3 year survival rate of renal transplantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preserving Kidney Function in Children With Chronic Kidney Disease

NCT05169411

Chronic Kidney Disease Stage 2 Chronic Kidney Disease Stage 3 Pediatric Kidney Disease

COMPLETED

Predictors of Outcome of Pediatric Renal Transplantation

NCT06708988

Pediatric Renal Transplantation Complication

NOT_YET_RECRUITING

Clinical and Basic Study for Pediatric Liver Transplantation

NCT02503384

Biliary Atresia Metabolic Disorders Fulminant Liver Failure +1 more

UNKNOWN

Clonal Deletion on Living-Relative Donor Kidney Transplantation

NCT01408797

Renal Transplantation Uremia

UNKNOWN PHASE1/PHASE2

Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial

NCT02948179

Polycystic Kidney, Type 1 Autosomal Dominant Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

molecular diagnosis confirmed

Whole exome sequencing is applied to children and the molecular diagnosis was identified before renal transplantation.

molecular diagnosis

Intervention Type DIAGNOSTIC_TEST

whole exome sequencing and data analysis to elucidating molecular diagnosis

molecular diagnosis unconfirmed

Whole exome sequencing is applied to children and the molecular diagnosis was not identified before renal transplantation.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

molecular diagnosis

whole exome sequencing and data analysis to elucidating molecular diagnosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Donors and recipients who accepted kidney transplantation at centers included in this study

Exclusion Criteria

* Older than 18 years old.
* There are severe systemic diseases and/or local and/or spiritual system diseases.
* There are systemic acute or chronic infections, infectious diseases.
* The donated organ dysfunction, or other causes that are damage to donors and recipients.

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No